Simvastatin inhibits 20-Hydroxyeicosatetraenoic acid formation: docking and in vitro assay

View Full Paper

Ask AI

Bookmark

Authors

Discussion

In vitro assay showed simvastatin inhibits 20-HETE formation in human liver microsomes, suggesting therapeutic potential.

Simvastatin effectively inhibits 20-hydroxyeicosatetraenoic acid formation, showing potential cardiovascular benefits.
The study determined an IC50 value of 10 µM for simvastatin's inhibitory effect on 20-HETE.
Molecular docking simulations indicated strong interactions between simvastatin and cytochrome P450 enzymes.
Simvastatin's mechanism involves competitive inhibition, highlighting its role as a possible therapeutic agent.

Jarrar et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark